Deutsche Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.35M | Buy |
257,525
+22,507
| +10% | +$1.01M | ﹤0.01% | 1069 |
|
|
2025
Q4 | $10.9M | Buy |
235,018
+2,653
| +1% | +$118K | ﹤0.01% | 1049 |
|
|
2025
Q3 | $9.68M | Buy |
232,365
+37,169
| +19% | +$1.19M | ﹤0.01% | 1062 |
|
|
2025
Q2 | $5.61M | Sell |
195,196
-8,926
| -4% | -$276K | ﹤0.01% | 1197 |
|
|
2025
Q1 | $6.85M | Sell |
204,122
-7,192
| -3% | -$269K | ﹤0.01% | 1131 |
|
|
2024
Q4 | $10.8M | Sell |
211,314
-4,803
| -2% | -$269K | ﹤0.01% | 1001 |
|
|
2024
Q3 | $11M | Buy |
216,117
+12,228
| +6% | +$631K | ﹤0.01% | 989 |
|
|
2024
Q2 | $9.13M | Buy |
203,889
+134,282
| +193% | +$6.2M | ﹤0.01% | 1034 |
|
|
2024
Q1 | $3.26M | Sell |
69,607
-10,820
| -13% | -$423K | ﹤0.01% | 1445 |
|
|
2023
Q4 | $2.86M | Buy |
80,427
+50,217
| +166% | +$1.54M | ﹤0.01% | 1489 |
|
|
2023
Q3 | $898K | Buy |
30,210
+7,125
| +31% | +$147K | ﹤0.01% | 1790 |
|
|
2023
Q2 | $416K | Sell |
23,085
-15,234
| -40% | -$304K | ﹤0.01% | 2458 |
|
|
2023
Q1 | $615K | Buy |
38,319
+9,062
| +31% | +$168K | ﹤0.01% | 2377 |
|
|
2022
Q4 | $535K | Buy |
29,257
+7,736
| +36% | +$136K | ﹤0.01% | 2412 |
|
|
2022
Q3 | $423K | Sell |
21,521
-3,442
| -14% | -$70.2K | ﹤0.01% | 2466 |
|
|
2022
Q2 | $466K | Sell |
24,963
-1,330
| -5% | -$26.5K | ﹤0.01% | 2644 |
|
|
2022
Q1 | $577K | Sell |
26,293
-2,978
| -10% | -$60.3K | ﹤0.01% | 2662 |
|
|
2021
Q4 | $832K | Sell |
29,271
-60,785
| -67% | -$1.5M | ﹤0.01% | 2550 |
|
|
2021
Q3 | $1.9M | Buy |
90,056
+970
| +1% | +$20.3K | ﹤0.01% | 2142 |
|
|
2021
Q2 | $1.68M | Buy |
89,086
+4,120
| +5% | +$72.4K | ﹤0.01% | 2393 |
|
|
2021
Q1 | $1.3M | Buy |
84,966
+64,495
| +315% | +$1,000K | ﹤0.01% | 2501 |
|
|
2020
Q4 | $289K | Buy |
20,471
+5,044
| +33% | +$70.3K | ﹤0.01% | 3247 |
|
|
2020
Q3 | $242K | Buy |
15,427
+1,306
| +9% | +$20K | ﹤0.01% | 3115 |
|
|
2020
Q2 | $247K | Buy |
14,121
+10,323
| +272% | +$176K | ﹤0.01% | 3033 |
|
|
2020
Q1 | $56K | Sell |
3,798
-222
| -6% | -$4.55K | ﹤0.01% | 3485 |
|
|
2019
Q4 | $100K | Buy |
4,020
+919
| +30% | +$17.5K | ﹤0.01% | 3577 |
|
|
2019
Q3 | $45K | Sell |
3,101
-177
| -5% | -$3.44K | ﹤0.01% | 3989 |
|
|
2019
Q2 | $81K | Sell |
3,278
-6,068
| -65% | -$150K | ﹤0.01% | 4310 |
|
|
2019
Q1 | $210K | Buy |
9,346
+2,500
| +37% | +$61.4K | ﹤0.01% | 3977 |
|
|
2018
Q4 | $203K | Sell |
6,846
-8,914
| -57% | -$251K | ﹤0.01% | 3870 |
|
|
2018
Q3 | $451K | Buy |
+15,760
| New | +$468K | ﹤0.01% | 3837 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC